Home  >  News
Eppen_Himac_Jan25
Waters_Ebook_Dec24
you can get e-magazine links on WhatsApp. Click here
News
  MiNK’s immune reconstitution to combat advanced gastroesophageal cancers with novel combination of Allo-iNKTs plus BOT/BAL presented at ASCO GI Symposium,   January 25, 2025
  AstraZeneca plans C$820 million investment in Canada to advance growing global hub and clinical delivery,   January 25, 2025
  Kelun-Biotech’s novel ADC drug SKB445 receives NMPA approval to treat advanced solid tumours,   January 24, 2025
  Altamira Therapeutics announces collaboration on radiopharmaceutical targeting strategies,   January 24, 2025
  Pharmapack award winners redefine packaging and drug delivery,   January 24, 2025
  ImaginAb signs agreement to sell proprietary novel biologics technology platform to Telix Pharma,   January 24, 2025
  Six start-ups bestowed with new ‘heart of pharma’ at Pharmapack Europe,   January 23, 2025
  US FDA grants breakthrough therapy designation to Bluejay Therapeutics’ brelovitug for treatment of chronic hepatitis delta,   January 23, 2025
  Solid Biosciences’ AAV-based gene therapy candidate, SGT-212 for Friedreich’s ataxia receives US FDA fast track designation,   January 23, 2025
  ArriVent BioPharma inks exclusive license with Lepu Biopharma for MRG007, an ADC to treat gastrointestinal cancers,   January 23, 2025
  DKSH expands exclusive partnership with Hygiena, a global leader in food safety and health diagnostics, to include Malaysia,   January 22, 2025
  Romaco earns gold level recognition in the EcoVadis sustainability ratings,   January 22, 2025
  Health Canada authorizes Roche’s Vabysmo pre-filled syringe for three leading causes of vision loss,   January 21, 2025
  Leaps by Bayer announces one of the largest global surveys of society’s attitudes toward breakthrough technologies,   January 21, 2025
  European Commission approves GSK’s Jemperli plus chemotherapy to treat patients with primary advanced or recurrent endometrial cancer,   January 21, 2025
  Chugai wins MHLW Minister’s Award at the Seventh Japan Medical Research and Development Grand Prize for discovery of an ALK-positive lung cancer treatment “Alecensa”,   January 20, 2025
  Amgen receives US FDA approval for Lumakras in combo with Vectibix for chemorefractory KRAS G12C-mutated metastatic colorectal cancer,   January 20, 2025
  Daiichi Sankyo & AstraZeneca’s Datroway gets US FDA approval for patients with previously treated metastatic HR positive, HER2 negative breast cancer,   January 20, 2025
  AstraZeneca’s Calquence plus chemoimmunotherapy approved in US for patients with previously untreated mantle cell lymphoma,   January 20, 2025
  Avicanna enters scientific and medical affairs collaboration with Vectura Fertin Pharma,   January 18, 2025

 Back
 
Asia_Lab_Expo2025
chemexpoindia
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram